IDH2 and lung carcinoma: Of these, Aco2 [28], Idh2 [29], Ndufs1 [30], Hadh [31], Dlat [32], Itgam [33], Dlat [34], Hadha [35], Mrpl11 [36], Dlst [34], and Hspd1 [37] show potential as oncoproteins and tumor suppressors and warrant further study for their possible role in inflammation-driven lung cancer.